11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.

      1 , 2 , 2
      Cutis

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Disseminated superficial actinic porokeratosis (DSAP) is a chronic condition characterized by numerous atrophic papules and patches with a distinctive peripheral keratotic ridge, typically found on sun-exposed areas. Treatment of DSAP is warranted not only for cosmetic and symptomatic benefits but also to prevent malignant transformation. Successful treatment of DSAP often is difficult and frequently requires the use of multiple modalities. Ingenol mebutate gel 0.05% is a topical medication primarily used for the treatment of actinic keratosis (AK) by inducing cell death. We report a case of DSAP treated effectively with ingenol mebutate gel 0.05%.

          Related collections

          Author and article information

          Journal
          Cutis
          Cutis
          2326-6929
          0011-4162
          Mar 2017
          : 99
          : 3
          Affiliations
          [1 ] McGill University, Montreal, Quebec, Canada.
          [2 ] Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
          Article
          28398427
          abe0b629-973a-4636-8c55-947bbc90f901
          History

          Comments

          Comment on this article